Radiation Oncology Journal

  • 제36권2호
  • /
  • Pages.163-170
  • /
  • 2018
  • /
  • 2234-1900(pISSN)
  • /
  • 2234-3156(eISSN)
대한방사선종양학회 (The Korean Society for Radiation Oncology)
권호 표지
DOI QR코드

DOI QR Code

Merkel cell carcinoma in the community setting: a case report

  • Callaghan, Cameron M. (Department of Radiation Oncology, Carver College of Medicine, The University of Iowa) ;
  • Amornmarn, Rumpa (Department of Radiation Oncology, Osceola Cancer Center)
  • 투고 : 2017.10.09
  • 심사 : 2018.01.15
  • 발행 : 2018.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin initially believed to arise from the Merkel cells. In the community setting a general radiation oncologist may only encounter this pathology in a handful of cases over the course of their career. Due to the low incidence of this malignancy, few prospective randomized controlled trials have ever been conducted and therefore guidelines are based on relatively lower levels of evidence upon which the clinical recommendations are made. We discuss the case of a female in her 90s presenting with a classic MCC primary lesion, as well as satellite lesions proximal to both the primary and the draining regional lymph nodes with no evidence of nodal involvement. Here we discuss the presentation, management, treatment planning, underlying pathology, results and sequelae of treatment. We also review new treatment modalities, and the most current staging systems and guidelines.

키워드

참고문헌

  1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-10. https://doi.org/10.1001/archderm.1972.01620040075020
  2. Tilling T, Moll I. Which are the cells of origin in Merkel cell carcinoma? J Skin Cancer 2012;2012:680410.
  3. Sauer CM, Haugg AM, Chteinberg E, et al. Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma. Crit Rev Oncol Hematol 2017;116:99-105. https://doi.org/10.1016/j.critrevonc.2017.05.009
  4. Amaral T, Leiter U, Garbe C. Merkel cell carcinoma: epidemiology, pathogenesis, diagnosis and therapy. Rev Endocr Metab Disord 2017;18:517-32. https://doi.org/10.1007/s11154-017-9433-0
  5. Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, Dias-Santagata D, Cusack JC. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol 2013;20:1365-73. https://doi.org/10.1245/s10434-012-2779-3
  6. Banks PD, Sandhu S, Gyorki DE, Johnston ML, Rischin D. Recent insights and advances in the management of Merkel cell carcinoma. J Oncol Pract 2016;12:637-46. https://doi.org/10.1200/JOP.2016.013367
  7. Schadendorf D, Lebbe C, Zur Hausen A, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer 2017;71:53-69. https://doi.org/10.1016/j.ejca.2016.10.022
  8. Fitzgerald TL, Dennis S, Kachare SD, Vohra NA, Wong JH, Zervos EE. Dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States. Am Surg 2015;81:802-6.
  9. Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol 2007;57:166-9. https://doi.org/10.1016/j.jaad.2007.03.011
  10. Tai P. Merkel cell cancer: update on biology and treatment. Curr Opin Oncol 2008;20:196-200. https://doi.org/10.1097/CCO.0b013e3282f46d5d
  11. Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol 2012;23:1074-80. https://doi.org/10.1093/annonc/mdr318
  12. Amin MB, Greene FL, Edge SB, et al. AJCC cancer staging manual. 8th ed. Cham, Switzerland: Springer International Publishing; 2017.
  13. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Merkel cell carcinoma 1.2018 [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2018 [cited 2018 Mar 1]. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx.
  14. Sakaida E, Ebata T, Iwasawa S, et al. Potential activity of amrubicin as a salvage therapy for Merkel cell carcinoma. Intern Med 2017;56:567-70. https://doi.org/10.2169/internalmedicine.56.7675
  15. Cao S, Nambudiri VE. Anaplastic lymphoma kinase in cutaneous malignancies. Cancers (Basel) 2017;9:123. https://doi.org/10.3390/cancers9090123
  16. Ritter C, Fan K, Paschen A, et al. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma. Sci Rep 2017;7:2290. https://doi.org/10.1038/s41598-017-02608-0
  17. Moshiri AS, Doumani R, Yelistratova L, et al. Polyomavirusnegative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection. J Invest Dermatol 2017;137:819-27. https://doi.org/10.1016/j.jid.2016.10.028
  18. Brenner B, Sulkes A, Rakowsky E, et al. Second neoplasms in patients with Merkel cell carcinoma. Cancer 2001;91:1358-62. https://doi.org/10.1002/1097-0142(20010401)91:7<1358::AID-CNCR1139>3.0.CO;2-C
  19. Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010;102:793-801. https://doi.org/10.1093/jnci/djq120
  20. Kim GJ, Lee JH, Lee DH. Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer. Medicine (Baltimore) 2017;96:e5413. https://doi.org/10.1097/MD.0000000000005413